Back to Search Start Over

105 - Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome.

Authors :
Li, H.
Wang, L.
Wu, Y.
Su, L.
Zhao, H.
Zhang, Y.
Wang, Z.
Huang, D.
Huang, Z.
Wu, X.
Li, X.
Ye, F.
Yu, F.
Liu, H.
Wang, J.
Cong, J.
Sun, W.
Chen, H.
Han, B.
Source :
Leukemia Research. Apr2017 Supplement 1, Vol. 55, pS65-S66. 1p.
Publication Year :
2017

Subjects

Subjects :
*DECITABINE
*MYELODYSPLASTIC syndromes treatment
*DRUG efficacy
*THERAPEUTICS

Details

Language :
English
ISSN :
01452126
Volume :
55
Database :
Academic Search Index
Journal :
Leukemia Research
Publication Type :
Academic Journal
Accession number :
123868608
Full Text :
https://doi.org/10.1016/S0145-2126(17)30218-7
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details